These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4412732)

  • 41. [Delayed-type hypersensitivity].
    Serov VV; Kakturskiĭ LV
    Arkh Patol; 1973; 35(6):3-19. PubMed ID: 4594092
    [No Abstract]   [Full Text] [Related]  

  • 42. Cellular immunity and blocking antibodies to tumors.
    Hellström I; Hellström KE
    J Reticuloendothel Soc; 1971 Jul; 10(1):131-6. PubMed ID: 5121177
    [No Abstract]   [Full Text] [Related]  

  • 43. [Principal immunologic factors in carcinogenesis].
    Melki G
    Cah Med; 1973 Oct; 14(10):821-37. PubMed ID: 4806157
    [No Abstract]   [Full Text] [Related]  

  • 44. Mechanism of cell-mediated cytotoxicity at the single cell level. VI. Direct assessment of the cytotoxic potential of human peripheral blood non-lytic effector-target cell conjugates.
    Bonavida B; Lebow LT; Bradley TP
    J Immunol; 1984 Feb; 132(2):594-8. PubMed ID: 6606675
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Immunology of melanoma].
    Vanwijck R; Bernheim JL; Lejeune FJ
    Acta Chir Belg; 1974 Mar; 73(2):135-88. PubMed ID: 4615541
    [No Abstract]   [Full Text] [Related]  

  • 46. The immune response and cancer. A guide.
    Gilbert HA; Kagan AR
    Radiol Clin Biol; 1974; 43(5):409-44. PubMed ID: 4605271
    [No Abstract]   [Full Text] [Related]  

  • 47. Histocompatibility (HL-A) antigens associated with myasthenia gravis. A preliminary report.
    Pirskanen R; Tiilikainen A; Hokkanen E
    Ann Clin Res; 1972 Oct; 4(5):304-6. PubMed ID: 4644453
    [No Abstract]   [Full Text] [Related]  

  • 48. Blocking of cell-mediated tumor immunity by sera from patients with growing neoplasms.
    Hellström I; Sjögren HO; Warner G; Hellström KE
    Int J Cancer; 1971 Mar; 7(2):226-37. PubMed ID: 5104167
    [No Abstract]   [Full Text] [Related]  

  • 49. Thymus-derived lymphocytes as effectors of cell-mediated immunity to syngeneic and allogeneic transplants in the rat.
    Tucker DF; Dennert G; Lennox ES
    J Immunol; 1974 Oct; 113(4):1302-12. PubMed ID: 4547337
    [No Abstract]   [Full Text] [Related]  

  • 50. Mechanism of complement action in rosette inhibition and lymphocytotoxicity of antilymphocyte serum.
    Bach JF; Gigli I; Dardenne M; Dormont J
    Immunology; 1972 Apr; 22(4):625-35. PubMed ID: 5016236
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Immunity factory].
    Ax W
    Arch Klin Exp Ohren Nasen Kehlkopfheilkd; 1970; 196(2):93-6. PubMed ID: 5494501
    [No Abstract]   [Full Text] [Related]  

  • 52. Antibody-dependent lymphoid cell-mediated cytotoxicity: role of complement.
    Van Boxel JA; Paul WE; Green I; Frank MM
    J Immunol; 1974 Jan; 112(1):398-403. PubMed ID: 4812178
    [No Abstract]   [Full Text] [Related]  

  • 53. HL-A antibodies and cold lymphocytotoxins.
    Mayer S; Falkenrodt A; Tongio MM
    Tissue Antigens; 1974; 4(4):387-94. PubMed ID: 4137710
    [No Abstract]   [Full Text] [Related]  

  • 54. Proceedings: What is the clinical relevance of in-vitro tumour immunity test?
    Moore M
    Br J Radiol; 1975 May; 48(569):413. PubMed ID: 1139106
    [No Abstract]   [Full Text] [Related]  

  • 55. Quantitation of the microassay for cell-mediated immunity through electronic image analysis.
    Takasugi M; Mickey MR; Terasaki PI
    Natl Cancer Inst Monogr; 1973 Jun; 37():77-84. PubMed ID: 4713786
    [No Abstract]   [Full Text] [Related]  

  • 56. [Factors contributing to the impairment of cellular immunity in cancer patients (author's transl)].
    Lin MH; Han SH
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1978 Mar; 11(1):1-7. PubMed ID: 308446
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Considerations on HL-A antigens and their isolation].
    Májský A
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(4):608-14. PubMed ID: 4139080
    [No Abstract]   [Full Text] [Related]  

  • 58. [Cytotoxic effect of decomplemented serum on human lymphocyte cultures in uremic patients].
    Krasojević I
    Srp Arh Celok Lek; 1976 May; 104(5):331-9. PubMed ID: 1019742
    [No Abstract]   [Full Text] [Related]  

  • 59. The role of human complement in the lymphocytotoxicity test.
    Gelsthorpe K; Doughty RW
    Transplantation; 1973 Apr; 15(4):347-53. PubMed ID: 4711013
    [No Abstract]   [Full Text] [Related]  

  • 60. Inhibition of lymphocyte-dependent antibody effector cell function by human anti-B-lymphocyte alloantiserum.
    Mikulski S; Billing R
    Cell Immunol; 1977 Jan; 28(1):69-74. PubMed ID: 299833
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.